The International Trade Commission published notices in the April 25 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register April 25 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department issued its final determination in its countervailing duty investigation of crystalline silicon photovoltaic cells, whether or not assembled into modules, from Cambodia (C-555-004), Malaysia (C-557-831), Thailand (C-549-852) and Vietnam (C-552-842), finding countervailable subsidization of producers and exporters in the four countries. Suspension of liquidation is currently not in effect for entries on or after Feb. 1, and Commerce will require cash deposits of estimated CVD on future entries only if it issues a CVD order.
The Commerce Department issued its final affirmative determinations in the antidumping duty investigations on crystalline silicon photovoltaic cells, whether or not assembled into modules, from Cambodia (A-555-003), Malaysia (A-557-830), Thailand (A-549-851) and Vietnam (A-552-841). Changes to cash deposit requirements set in these final determinations take effect April 25, the date they were published in the Federal Register.
The Commerce Department issued notices in the Federal Register on its recently initiated antidumping duty investigations on monomers and oligomers from Korea and Taiwan, as well as its countervailing duty investigation on monomers and oligomers from Taiwan. The AD/CVD investigations cover entries for calendar year 2024.
The International Trade Commission published notices in the April 24 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register April 24 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The International Trade Commission has ended a Section 337 investigation on imports of laptop and desktop computers, tablet computers, streaming devices, televisions, cameras and components from Amazon and HP (ITC Inv. No. 337-TA-1379), it said in a notice to be published April 25. Complainant Nokia initially alleged in 2023 that Amazon and HP were importing various electronics that infringe seven of Nokia's patents covering motion compensated prediction inventions, improvements to video decoding techniques, encoding and decoding, and video compression (see 2311030010).
The International Trade Commission seeks comments by May 2 on a Section 337 complaint alleging that imports of integrated circuits and electronic devices infringe patents held by Onesta IP, it said in a notice set for April 24 publication. According to the complaint, Onesta, whose domestic licensee is Advanced Micro Devices, is seeking a limited exclusion order and cease and desist orders against NVIDIA, Qualcomm, OnePlus Technology and Nothing Technology Limited to bar from entry "certain integrated circuits, electronic devices containing the same, and components thereof," that violate the complainant's patents. The complainant said that the patents "generally relate to integrated circuits, processors, and systems comprising a central processing unit and/or a graphics processing unit supporting various advanced computing, graphics processing, power management, memory operation, and chip design features."
The International Trade Commission seeks comments by May 2 on a Section 337 complaint alleging that imports of balloon dilation devices infringe patents held by Entellus Medical, Stryker Corporation, and Stryker Sales, it said in a notice set for April 24 publication. According to the complaint, the complainants are seeking a limited exclusion order and cease and desist orders against German company Fiagon and U.S. parent company Hemostasis to bar from entry "certain balloon dilation devices, systems, and components thereof," that violate the complainant's patents. The complainants described the products as medical "components for tracking, guiding, illuminating, and/or navigating" for "illuminating nasal and sinus cavities for treatment of sinusitis."